Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP

Oncogene

Volumn 29, Issue 24, 2010, Pages 3501-3508

  Ji, P ^a   Smith, S M ^a,b   Wang, Y ^a,c   Jiang, R ^a,c   Song, S W ^a,d   Li, B ^e   Sawaya, R ^a   Bruner, J M ^a   Kuang, J ^a   Yu, H ^e   Fuller, G N ^a   Zhang, W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b The University of Texas at Austin   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

APC CCdc20; Centrosome; Gliomagenesis; MIIP; Mitotic catastrophe; Mitotic transition

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN 20; CYCLIN B1; MIGRATION AND INVASION INHIBITOR PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ATTENUATION; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA; GLIOMAGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN B1; DISEASE PROGRESSION; GLIOMA; HUMANS; MICE; MICE, TRANSGENIC; MITOSIS; NEUROGLIA; ORGAN SPECIFICITY; PROTEIN STABILITY; UBIQUITIN-PROTEIN LIGASES;

EID: 77953792438     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.114     Document Type: Article

References (30)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. (2003). Primary brain tumours in adults. Lancet 361: 323-331.
2. Demuth T, Berens ME. (2004). Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70: 217-228.
3. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN et al. (2007). Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA 104: 11736-11741.
4. Fang G, Yu H, Kirschner MW. (1998). Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell 2: 163-171.
5. Fraschini R, Formenti E, Lucchini G, Piatti S. (1999). Budding yeast Bub2 is localized at spindle pole bodies and activates the mitotic checkpoint via a different pathway from Mad2. J Cell Biol 145: 979-991.
6. Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V et al. (2008). CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst 100: 940-949.
7. Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode EL et al. (1999). Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 64: 776-787.
8. Hoffman S, Propp JM, McCarthy BJ. (2006). Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 8: 27-37.
9. Holland EC, Hively WP, DePinho RA, Varmus HE. (1998). A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12: 3675-3685.
10. Homer HA, McDougall A, Levasseur M, Murdoch AP, Herbert M. (2005). Mad2 is required for inhibiting securin and cyclin B degradation following spindle depolymerisation in meiosis I mouse oocytes. Reproduction 130: 829-843.
11. Janoueix-Lerosey I, Novikov E, Monteiro M, Gruel N, Schleiermacher G, Loriod B et al. (2004). Gene expression profiling of 1p35-36 genes in neuroblastoma. Oncogene 23: 5912-5922.
12. Li Y, Benezra R. (1996). Identification of a human mitotic checkpoint gene: hsMAD2. Science 274: 246-248.
13. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al. (2001). Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
14. Miller JJ, Summers MK, Hansen DV, Nachury MV, Lehman NL, Loktev A et al. (2006). Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor. Genes Dev 20: 2410-2420.
15. Munirajan AK, Ando K, Mukai A, Takahashi M, Suenaga Y, Ohira M et al. (2008). KIF1Bbeta functions as a haplo-insufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 283: 24426-24434.
16. Nilsson J, Yekezare M, Minshull J, Pines J. (2008). The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10: 1411-1420.
17. Ohgaki H, Kleihues P. (2005). Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligoden-droglial gliomas. J Neuropathol Exp Neurol 64: 479-489.
18. Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, Sherman NE et al. (2006). SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 23: 319-329.
19. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. (1999). Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 79: 1468-1474.
20. Reimann JD, Gardner BE, Margottin-Goguet F, Jackson PK. (2001). Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev 15: 3278-3285.
21. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G et al. (1999). Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144-4152.
22. Song F, Ji P, Zheng H, Wang Y, Hao X, Wei Q et al. (2010). Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene MIIP that affects the risk of breast cancer. Cancer Res 70: 1024-1032.
23. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK et al. (2004). The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6: 129-137.
24. Song SW, Fuller GN, Khan A, Kong S, Shen W, Taylor E et al. (2003). IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci USA 100: 13970-13975.
25. Song SW, Fuller GN, Zheng H, Zhang W. (2005). Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. Cancer Res 65: 3562-3567.
26. Tang Z, Shu H, Oncel D, Chen S, Yu H. (2004). Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint. Mol Cell 16: 387-397.
27. Wolthuis R, Clay-Farrace L, van Zon W, Yekezare M, Koop L, Ogink J et al. (2008). Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol Cell 30: 290-302.
28. Wu Y, Song SW, Sun J, Bruner JM, Fuller GN, Zhang W. (2010). IIp45 inhibits cell migration through inhibition of HDAC6. J Biol Chem 285: 3554-3560.
29. Yamano H, Gannon J, Mahbubani H, Hunt T. (2004). Cell cycle-regulated recognition of the destruction box of cyclin B by the APC/C in Xenopus egg extracts. Mol Cell 13: 137-147.
30. Yu H. (2007). Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 27: 3-16.